|
Subgroups
|
Studies, n
|
Prevalence (%)
|
95%CI
|
Heterogeneity within the study (I2, Value)
|
Heterogeneity between groups (P value)
|
|---|
|
I2 (%)
|
P value
|
|---|
|
Country
|
|
Developed
|
8
|
42.09
|
27.29–58.47
|
99.38
|
<0.001
|
0.028
|
|
Developing
|
17
|
24.52
|
19.66–30.14
|
97.34
|
<0.001
| |
|
Tools used
|
|
AUDIT
|
23
|
31.52
|
25.66–38.02
|
98.75
|
<0.001
|
<0.001
|
|
CIDI
|
2
|
13.51
|
11.86–15.34
|
2.13
|
0.312
| |
|
Gender
|
|
Male
|
15
|
26.90
|
19.72–35.53
|
97.92
|
<0.001
| |
|
Female
|
15
|
13.37
|
8.79–19.80
|
97.03
|
<0.001
|
<0.001
|
|
Quality of studies
| | | | | |
0.598
|
|
High
|
19
|
28.50
|
22.42–35.49
|
98.89
|
<0.001
| |
|
Moderate and poor
|
6
|
33.19
|
18.97–51.33
|
98.54
|
<0.001
| |
